Belvedere Trading’s Exelixis EXEL Stock Holding History

Belvedere Trading’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,513	Closed	-$404K	–	312
2022 Q2	$404K	Buy	18,513 +7,778	+72%	+$160K	0.01%	105
2022 Q1	$244K	Buy	+10,735	New	+$210K	0.01%	210

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Belvedere Trading's EXEL Position: Q3 2022 in Review

Belvedere Trading sold out of Exelixis (EXEL) in Q3 2022, closing a stake of 18,513 shares — an estimated $404K sold.

Belvedere Trading first reported a position in EXEL in Q1 2022 and held it in 2 quarters. The position peaked at $404K in Q2 2022. 400 funds tracked by Wall St. Rank hold EXEL as of Q3 2022.

Belvedere Trading reported no remaining Exelixis position as of Q3 2022 after selling out during the quarter.
Belvedere Trading sold 18,513 Exelixis shares in Q3 2022, an estimated $404K.
Belvedere Trading first reported a position in Exelixis in Q1 2022 and held it in 2 quarters.
Belvedere Trading's Exelixis position peaked at $404K in Q2 2022.
400 funds tracked by Wall St. Rank held Exelixis as of Q3 2022.

Based on Belvedere Trading's 13F filing for Q3 2022, filed 26 Oct 2022.